Two notable executives in Maine’s tech sector are in the process of updating their resumes.
Taking Maine expertise global
After helping Ocean Renewable Power Co. become known as one of the most innovative energy companies in the country, John Ferland is taking on a new role as president of its spin-off consulting business, ORPC Solutions.
John Ferland, VP of project development at Ocean Renewable Power Co., has taken on new role as president of the company’s consulting spin-off business. In this Press Herald file photo, Ferland stands inside one of the ORPC turbines now installed off the waters of Eastport. (John Patriquin/Staff Photographer)
Portland-based ORPC made history in 2012 when its tidal energy project in Cobscook Bay became the first ocean energy project of any kind in the Americas to deliver electricity to the power grid. As it continues to work on that project and others, including the installation of underwater turbines in a river in Alaska, the company recognized it could leverage that experience by offering it to other companies seeking to get ocean energy projects online. Ferland is now leading those efforts at ORPC Solution, while retaining his job title as VP of project development at the parent company.
“John’s winning approach to ORPC’s project and market development, community outreach efforts, and regulatory agency and fishermen relations, has been key to our pioneering success in the ocean energy industry,” ORPC President Chris Sauer said in a statement. “We are incredibly lucky to have such a seasoned professional step into the lead role for ORPC Solutions.”
FHC to Biovation
Keri Seitz has joined Biovation as VP of sales and customer relations
Keri Seitz has left her position as CEO of Bowdoin-based FHC Inc., which develops and sells products used in neuroscience research, to pursue new challenges at Biovation, the Boothbay-based manufacturer of high-tech fiber products used in the medical and defense industries.
Seitz has taken a job as VP of sales and customer relations at Biovation. Her experience in the medical device marketplace will help Biovation expand its global sales efforts, according to Kerem Durdag, Biovation’s CEO. Under Seitz’s tenure at FHC, the company increased revenue by almost 40 percent and quadrupled net operating profit, according to a news release.
“Keri is the right person to lead us in our next stage of growth given her deep experience in delivering rapid revenue growth and increasing market share,” Durdag said in a statement.
Send questions/comments to the editors.
Success. Please wait for the page to reload. If the page does not reload within 5 seconds, please refresh the page.
Enter your email and password to access comments.
Hi, to comment on stories you must . This profile is in addition to your subscription and website login.
Already have a commenting profile? .
Invalid username/password.
Please check your email to confirm and complete your registration.
Only subscribers are eligible to post comments. Please subscribe or login first for digital access. Here’s why.
Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.